Recent Updates
Recently added Catalysts
TECX Positive Sentiment

Tectonic Therapeutic to Participate in March Investor Conferences

Key Takeaway: Tectonic Therapeutic, a clinical-stage biotech firm, will participate in two investor conferences in March 2026. The company's management will host one-on-one meetings and fireside chats, which will be accessible on their website. Tectonic is focused on developing therapeutic proteins and antibodies targeting GPCRs to address unmet medical needs.
Price reaction · baseline $23.45 (2026-02-27 close) · hit pre-market · clean, no other TECX news in the window
day 0 close
-1.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Tectonic Therapeutic is actively engaging with investors.
  • Participation in two investor conferences indicates strong market interest.
  • The company focuses on significant unmet medical needs.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+72%
120-day peak, hindsight
Typical move
9%
average across 2 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
TX000045- Dose A
Phase 2 · Pulmonary Hypertension

Full Press Release Details

WATERTOWN, Mass., March 02, 2026 (GLOBE NEWSWIRE) --Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company management will participate in two upcoming investor conferences taking place in March 2026.
TD Cowen 46th Annual Health Care Conference
Date: March 4, 2026
Time: 11:10 AM EST
Location: Boston, MA
Format: Fireside Chat
Presenters: Alise Reicin, MD, President and Chief Executive Officer
Webcast: Link
Leerink Global Healthcare Conference
Date: March 11, 2026
Time: 1:40 PM EST
Location: Miami, FL
Format: Fireside Chat
Presenters: Alise Reicin, MD, President and Chief Executive Officer
Webcast: Link
The live fireside chats can also be accessed under “Events & Presentations” on the Investors section of the Tectonic website atwww.tectonictx.com. A replay of the webcasts will be available on the Company’s website for approximately 90 days.
The Tectonic management team will host one-on-one meetings during the two conferences. Interested investors should contact their TD Cowen and Leerink representatives to schedule meetings.
About TectonicTectonic Therapeuticis a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Leveraging its proprietary technology platform called GEODe™ (GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visitwww.tectonictx.comand follow us onLinkedIn.

Frequently Asked Questions

What is Tectonic Therapeutic focused on?

Tectonic Therapeutic focuses on discovering and developing therapeutic proteins and antibodies that modulate GPCR activity.

When will Tectonic participate in investor conferences?

Tectonic will participate in two investor conferences taking place in March 2026.

How can investors access the conferences?

Investors can access the fireside chats on Tectonic's website under the 'Events & Presentations' section.

What technology platform does Tectonic use?

Tectonic utilizes a proprietary technology platform called GEODe™ for drug discovery.

Last updated: Mar 2, 2026